 | Up a level |
Verardi, Fabio; Maul, Lara Valeska; Borsky, Kim; Steinmann, Simona; Rosset, Nina; Pons, Hector Ortega; Sorbe, Christina; Yawalkar, Nikhil; Micheroli, Raphael; Egeberg, Alexander; Thyssen, Jacob P; Heidemeyer, Kristine; Boehncke, Wolf-Henning; Conrad, Curdin; Cozzio, Antonio; Pinter, Andreas; Kündig, Thomas; Navarini, Alexander A; Maul, Julia-Tatjana (2024). Sex differences in adverse events from systemic treatments for psoriasis: A decade of insights from the Swiss Psoriasis Registry (SDNTT). Journal of the European Academy of Dermatology and Venereology : JEADV, 38(4), pp. 719-731. Wiley 10.1111/jdv.19730
Conrad, Curdin; Schlapbach, Christoph (2024). Prurigo nodularis forecast: light Th2 inflammation, with high chances of fibrosis. The Journal of allergy and clinical immunology, 153(1), pp. 93-94. Elsevier 10.1016/j.jaci.2023.11.003
Kwatra, Shawn G; Yosipovitch, Gil; Legat, Franz J; Reich, Adam; Paul, Carle; Simon, Dagmar; Naldi, Luigi; Lynde, Charles; De Bruin-Weller, Marjolein S; Nahm, Walter K; Sauder, Maxwell; Gharib, Rola; Barbarot, Sebastien; Szepietowski, Jacek C; Conrad, Curdin; Fleischer, Alan; Laquer, Vivian T; Misery, Laurent; Serra-Baldrich, Esther; Lapeere, Hilde; ... (2023). Phase 3 Trial of Nemolizumab in Patients with Prurigo Nodularis. The New England journal of medicine, 389(17), pp. 1579-1589. Massachusetts Medical Society 10.1056/NEJMoa2301333
Schlapbach, Christoph; Conrad, Curdin (2022). TYK-ing all the boxes in psoriasis. Journal of allergy and clinical immunology, 149(6), pp. 1936-1939. Elsevier 10.1016/j.jaci.2022.03.014
van Huizen, Astrid M; Menting, Stef P; Gyulai, Rolland; Iversen, Lars; van der Kraaij, Gayle E; Middelkamp-Hup, Maritza A; Warren, Richard B; Spuls, Phyllis I; Schejtman, Adrián A; Egeberg, Alexander; Firooz, Alireza; Kumar, Alur S; Oakley, Amanda; Foulkes, Amy; Ramos, Andrea Machado Coelho; Fougerousse, Anne-Claire; Carija, Antoanela; Akman-Karakas, Ayse; Horváth, Barbara; Fábos, Béata; ... (2022). International eDelphi Study to Reach Consensus on the Methotrexate Dosing Regimen in Patients With Psoriasis. JAMA dermatology, 158(5), pp. 561-572. American Medical Association 10.1001/jamadermatol.2022.0434
Domizio, Jeremy Di; Gulen, Muhammet F; Saidoune, Fanny; Thacker, Vivek V; Yatim, Ahmad; Sharma, Kunal; Nass, Théo; Guenova, Emmanuella; Schaller, Martin; Conrad, Curdin; Goepfert, Christine; de Leval, Laurence; Garnier, Christophe von; Berezowska, Sabina; Dubois, Anaëlle; Gilliet, Michel; Ablasser, Andrea (2022). The cGAS-STING pathway drives type I IFN immunopathology in COVID-19. Nature, 603(7899), pp. 145-151. Springer Nature 10.1038/s41586-022-04421-w
Maul, Julia-Tatjana; Anzengruber, Florian; Conrad, Curdin; Cozzio, Antonio; Häusermann, Peter; Jalili, Ahmad; Kolios, Antonios G A; Laffitte, Emmanuel; Lapointe, Anne-Karine; Mainetti, Carlo; Schlapbach, Christoph; Trüeb, Ralph; Yawalkar, Nikhil; Dippel, Michaela; Navarini, Alexander A (2021). Topical Treatment of Psoriasis Vulgaris: The Swiss Treatment Pathway. Dermatology, 237(2), pp. 166-178. Karger 10.1159/000512930
Salomé, Bérengère; Gomez-Cadena, Alejandra; Loyon, Romain; Suffiotti, Madeleine; Salvestrini, Valentina; Wyss, Tania; Vanoni, Giulia; Ruan, Dan Fu; Rossi, Marianna; Tozzo, Alessandra; Tentorio, Paolo; Bruni, Elena; Riether, Carsten; Jacobsen, Eva-Maria; Jandus, Peter; Conrad, Curdin; Hoenig, Manfred; Schulz, Ansgar; Michaud, Katarzyna; Della Porta, Matteo Giovanni; ... (2019). CD56 as a marker of an ILC1-like population with NK cell properties that is functionally impaired in AML. Blood advances, 3(22), pp. 3674-3687. American Society of Hematology 10.1182/bloodadvances.2018030478
Senra, Luisa; Mylonas, Alessio; Kavanagh, Ruairi D; Fallon, Padraic G; Conrad, Curdin; Borowczyk-Michalowska, Julia; Wrobel, Ludovic Jean; Kaya, Guerkan; Yawalkar, Nikhil; Boehncke, Wolf-Henning; Brembilla, Nicolo Costantino (2019). IL-17E (IL-25) Enhances Innate Immune Responses during Skin Inflammation. Journal of investigative dermatology, 139(8), 1732-1742.e17. Elsevier 10.1016/j.jid.2019.01.021
Micossé, Claire; von Meyenn, Karl-Leonhard; Steck, Oliver; Kipfer, Enja; Adam, Christian; Simillion, Cedric; Jafari, Morteza; Olah, Peter; Yawalkar, Nikhil; Simon, Dagmar; Borradori, Luca; Kuchen, Stefan; Yerly, Daniel; Homey, Bernhard; Conrad, Curdin; Snijder, Berend; Schmidt, Marc; Schlapbach, Christoph (2019). Human "TH9" cells are a subpopulation of PPAR-γ+ TH2 cells. Science immunology, 4(31) American Association for the Advancement of Science 10.1126/sciimmunol.aat5943
Hartwig, Tom; Zwicky, Pascale; Schreiner, Bettina; Yawalkar, Nikhil; Cheng, Phil; Navarini, Alexander; Dummer, Reinhard; Flatz, Lukas; Conrad, Curdin; Schlapbach, Christoph; Becher, Burkhard (2018). Regulatory T Cells Restrain Pathogenic T Helper Cells during Skin Inflammation. Cell reports, 25(13), 3564-3572.e4. Cell Press 10.1016/j.celrep.2018.12.012
Feldmeyer, Laurence; Mylonas, Alessio; Demaria, Olivier; Mennella, Anna; Yawalkar, Nikhil; Laffitte, Emmanuel; Hohl, Daniel; Gilliet, Michel; Conrad, Curdin (2017). Interleukin 23-Helper T Cell 17 Axis as a Treatment Target for Pityriasis Rubra Pilaris. JAMA dermatology, 153(4), pp. 304-308. American Medical Association 10.1001/jamadermatol.2016.5384
Kolios, Antonios G A; Yawalkar, Nikhil; Anliker, Mark; Boehncke, Wolf-Henning; Borradori, Luca; Conrad, Curdin; Gilliet, Michel; Häusermann, Peter; Itin, Peter; Laffitte, Emmanuel; Mainetti, Carlo; French, Lars E; Navarini, Alexander A (2016). Swiss S1 Guidelines on the Systemic Treatment of Psoriasis Vulgaris. Dermatology, 232(4), pp. 385-406. Karger 10.1159/000445681
Maul, Julia-Tatjana; Djamei, Vahid; Kolios, Antonios G A; Meier, Barbara; Czernielewski, Justine; Jungo, Pascal; Yawalkar, Nikhil; Mainetti, Carlo; Laffitte, Emmanuel; Spehr, Christina; Anliker, Mark; Streit, Markus; Augustin, Matthias; Rustenbach, Stephan; Conrad, Curdin; Hafner, Jürg; Boehncke, Wolf-Henning; Borradori, Luca; Gilliet, Michel; Itin, Peter; ... (2016). Efficacy and Survival of Systemic Psoriasis Treatments: An Analysis of the Swiss Registry SDNTT. Dermatology, 232(6), pp. 640-647. Karger 10.1159/000452740
Jungo, Pierre; Maul, Julia-Tatjana; Djamei, Vahid; von Felten, Stefanie; Kolios, Antonios G A; Czernielewsk, Justine; Yawalkar, Nikhil; Odermatt, Olivia; Laffitte, Emmanuel; Anliker, Mark; Streit, Markus; Augustin, Matthias; Conrad, Curdin; Hafner, Jürg; Boehncke, Wolf-Henning; Gilliet, Michel; Itin, Peter; French, Lars E; Navarini, Alexander A and Häusermann, Peter (2016). Superiority in Quality of Life Improvement of Biologics over Conventional Systemic Drugs in a Swiss Real-Life Psoriasis Registry. Dermatology, 232(6), pp. 655-663. Karger 10.1159/000455042
Boehncke, Wolf-Henning; Anliker, Mark David; Conrad, Curdin; Dudler, Jean; Hasler, Fritz; Hasler, Paul; Häusermann, Peter; Kyburz, Diego; Laffitte, Emmanuel; Michel, Beat A; Möller, Burkhard; Navarini, Alexander A; Villiger, Peter; Yawalkar, Nikhil; Gabay, Cem (2015). The dermatologists' role in managing psoriatic arthritis: results of a swiss delphi exercise intended to improve collaboration with rheumatologists. Dermatology, 230(1), pp. 75-81. Karger 10.1159/000367688
Lande, Roberto; Botti, Elisabetta; Jandus, Camilla; Dojcinovic, Danijel; Fanelli, Giorgia; Conrad, Curdin; Chamilos, Georgios; Feldmeyer, Laurence; Marinari, Barbara; Chon, Susan; Vence, Luis; Riccieri, Valeria; Guillaume, Phillippe; Navarini, Alex A; Romero, Pedro; Costanzo, Antonio; Piccolella, Enza; Gilliet, Michel; Frasca, Loredana (2015). Corrigendum: the antimicrobial peptide LL37 is a T-cell autoantigen in psoriasis. Nature communications, 6, p. 6595. Nature Publishing Group 10.1038/ncomms7595
